Certain home sleep testing products, systems, software and services offered by Beacon Biosignals, Inc. and/or Beacon Bio Dx, LLC (“Beacon”), including Beacon’s current home sleep testing products and any successor, replacement, renamed or upgraded versions of those products (collectively, the “Beacon HST Products”), are covered by one or more United States patents owned by Cleveland Medical Devices Inc. and licensed to Beacon Bio Dx, LLC.

This webpage is intended to provide notice under 35 U.S.C. § 287(a). The following U.S. patents may apply to one or more Beacon HST Products and/or their use:

U.S. Patent Nos.:

7,942,824;

8,172,766;

8,545,416;

8,679,012;

9,202,008;

9,492,105;

9,533,114;

9,730,632;

9,943,252;

D663,430;

10,028,698;

10,076,269;

10,413,222;

10,426,399;

10,478,118;

10,543,328;

10,925,535;

11,064,937;

11,202,603;

11,234,637;

11,317,856;

11,382,562;

11,395,623;

11,419,525;

11,432,724;

11,478,188;

11,484,255;

11,576,610;

11,602,305;

11,688,503;

11,908,567;

12,016,679;

12,315,618;

12,458,280;

12,465,240;

12,471,806; and

12,484,843.

One or more Beacon HST Products, services, features, methods of operation or applications may also be covered by additional issued U.S. or foreign patents or by pending patent applications.

The inclusion of a patent on this page does not mean that every Beacon product is covered by every listed patent. Patent coverage depends upon the particular product, system, service, feature, configuration, method or application.

The patents identified above are owned by Cleveland Medical Devices Inc. Beacon Bio Dx, LLC’s rights under those patents arise under a written patent license agreement with Cleveland Medical Devices Inc.

Last updated: August 21, 2026.